News
The U.S. Food and Drug Administration recently approved a new drug to treat a severe form of asthma, based in part on research conducted by Eugene Bleecker, MD, co-director of the Division of Pharmacogenomics in the UA Health Sciences Center for Applied Genetics and Genomic Medicine (TCAG2M) and a professor and co-chief of the Division of Genetics, Genomics, and Precision Medicine in the UA Department of Medicine.
UA Health Sciences Asthma and Airway Disease Research Center respiratory scientist Dr. Stefano Guerra will lead an international effort—in partnership with investigative cohorts in Sweden and the UK—to target deficits of the protein CC16 as an indicator of likely persistence of asthma into adulthood.
In case you missed it, here’s a link to an op-ed article co-written by the University of Arizona’s Kimberly Andrews Espy, PhD, senior vice president for research, and Leigh Neumayer, MD, interim senior vice president for health sciences, on federally funded research under way at the UA to ease breathing woes of those suffering from asthma that advances a personalized medicine approach to diagnoses and treatment.
Parents of children with asthma can breathe easier thanks to a bill recently signed by Gov. Doug Ducey allowing Arizona schools to stock and administer asthma medication to children experiencing respiratory distress.
House dust differences between Amish and Hutterite communities affect immune development and asthma risk, according to study co-authored by University of Arizona Health Sciences researcher Dr. Donata Vercelli published today in the New England Journal of Medicine.
Leaders at the University of Arizona Health Sciences predict that a preventive medicine will be a landmark achievement in the history of asthma research. The national study is funded by a $27 million National Heart, Lung, and Blood Institute grant.
Center to focus on translational studies of asthma immunology, epidemiology, prevention, diagnosis and treatment
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.